Barinthus Biotherapeutics (BRNS) Earnings Date & Reports

Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company focused on developing novel immunotherapeutic drug candidates for treating autoimmune and inflammatory diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

BRNS is expected to report earnings to rise 11.54% to -28 cents per share on November 05

Barinthus Biotherapeutics BRNS Stock Earnings Reports

Q3'26

Est.

$-0.29

Q2'26

Beat

by $0.02

Q1'26

Beat

by $0.18

Q4'25

Beat

by $0.11

Q3'25

Beat

by $0.04

The last earnings report on August 06 showed earnings per share of -25 cents, beating the estimate of -28 cents. With 9.17K shares outstanding, the current market capitalization sits at 25.44M.

View a ticker or compare two or three

BRNS

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

Last 5 trading days